Treatment of Uncomplicated Urinary Tract Infections in Women

First-Line Treatment Options

The European Urology guidelines recommend nitrofurantoin monohydrate/macrocrystals (100 mg twice daily for 5 days), fosfomycin trometamol (3 g single dose), or pivmecillinam (400 mg three times daily for 3-5 days) as first-line treatment for uncomplicated UTIs in women due to their effectiveness and minimal resistance patterns 1, 2
Nitrofurantoin monohydrate/macrocrystals is highly recommended due to minimal resistance and limited collateral damage, with efficacy comparable to 3-day trimethoprim-sulfamethoxazole regimens 3, 4
Fosfomycin trometamol is appropriate for uncomplicated cystitis with minimal resistance, though it may have slightly lower efficacy compared to standard short-course regimens 3, 1
Pivmecillinam is effective where available, primarily in European countries 3, 1

Trimethoprim-sulfamethoxazole (160/800 mg twice daily for 3 days) should only be used if local resistance rates are known to be <20% or if the infecting strain is confirmed susceptible 3
Cephalosporins, such as cefadroxil 500 mg twice daily for 3 days, can be used if local E. coli resistance patterns are <20% 1
Trimethoprim (200 mg twice daily for 5 days) may be used but is contraindicated in the first trimester of pregnancy 1

Short-course therapy is preferred for uncomplicated UTIs to minimize side effects and resistance development 5
Nitrofurantoin requires 5 days of treatment for optimal efficacy 1, 4
Fosfomycin is administered as a single 3g dose 1
Trimethoprim-sulfamethoxazole is typically given for 3 days 3

Urine cultures are not routinely needed before treatment of uncomplicated UTIs in women with typical symptoms and no vaginal discharge 1, 6
Urine cultures should be obtained for suspected pyelonephritis, symptoms that don't resolve within 4 weeks after treatment, atypical symptoms, or in pregnant women 1
For women whose symptoms don't resolve by the end of treatment or recur within 2 weeks, perform urine culture and antimicrobial susceptibility testing 1
Retreatment with a 7-day regimen using a different antibiotic should be considered for treatment failures 1

Fluoroquinolones should be reserved for more serious infections due to their propensity for collateral damage, despite high efficacy 3, 4
Beta-lactams should be used only when recommended agents cannot be used 3
Symptomatic therapy, such as ibuprofen, may be considered as an alternative to antibiotics for women with mild to moderate symptoms, after discussing risks and benefits 1

Nitrofurantoin has demonstrated clinical cure rates of 88-95% and bacterial cure rates of 74-92% in clinical trials 7
Trimethoprim-sulfamethoxazole shows clinical cure rates of 90-95% and bacterial cure rates of 91-93% when the organism is susceptible 7
Fosfomycin has shown clinical cure rates of 90-95% and bacterial cure rates of 78-86% 7

Local resistance patterns should guide empiric therapy, particularly for trimethoprim-sulfamethoxazole 3